IntraBio
Mitchell A Kline MD is a highly experienced medical professional with a long-standing career in dermatology, serving as a Clinical Assistant Professor at Weill Cornell Medical College since July 1990 and as the owner of Mitchell A Kline MD PC, a practice focused on dermatologic surgery and melanoma diagnosis. Kline has held various positions, including venture capital at IntraBio Ltd. since May 2018, affiliate with the Melanoma Research Foundation since 2010, and membership on the Clinical Board of the Melanoma Research Alliance since 2009. Additionally, Kline has been a researcher at Lucid Technologies Inc. since 2005, a board member of Global Partners in Health since 1998, and has contributed to the field of dermatology through extensive education, including degrees from the University of Pennsylvania and Cornell University.
This person is not in any teams
This person is not in any offices
IntraBio
IntraBio is a biopharmaceutical company with a late-stage drug pipeline that includes novel treatments for genetic and neurodegenerative diseases.Their clinical programs leverage the expertise of their scientific founders from the University of Oxford and University of Munich, the preeminent experts and pioneers in discovering and developingsmall molecule drugs that modulate lysosomal function and intracellular calcium signaling.Their management team and business consultants have vast commercial and regulatory experience in drug product development, including all stages from small molecule manufacturing, clinical studies, and regulatory approvals in the USA and Europe.With their successful track record of drug development and commercialization, IntraBio’s team translates research in the fields of lysosomal biology, autophagy, and neurology into orphan drugs and treatments that will significantly improve the lives of patients, their caregivers, and families.